Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02902926
Other study ID # 20160805
Secondary ID
Status Recruiting
Phase N/A
First received August 15, 2016
Last updated September 12, 2016
Start date September 2016
Est. completion date March 2017

Study information

Verified date September 2016
Source Yangzhou University
Contact Tianqi Zhou, Dr.
Phone +8618852727248
Email 651299080@qq.com
Is FDA regulated No
Health authority China: YangZhou Science and Technology Bureau
Study type Interventional

Clinical Trial Summary

IBS is a global disease, patients often because of long-term symptoms of recurrent, not timely diagnosis and treatment effect is not ideal and frequent treatment, seriously affect the quality of life, and cause the corresponding economic and social burden.At present,a number of studies suggest that fermentable oligosaccharides, disaccharides and monosaccharides and polyols (FODMAPs) can induce IBS symptoms.Data from large randomized controlled trials are limited, leaving clinicians with the challenge of providing patients with reliable guidance based on minimal evidence.


Description:

IBS is a global disease, patients often because of long-term symptoms of recurrent, not timely diagnosis and treatment effect is not ideal and frequent treatment, seriously affect the quality of life, and cause the corresponding economic and social burden.At present,a number of studies suggest that fermentable oligosaccharides, disaccharides and monosaccharides and polyols (FODMAPs) can induce IBS symptoms.Data from large randomized controlled trials are limited, leaving clinicians with the challenge of providing patients with reliable guidance based on minimal evidence.

This study will compare the effect of low FODMAPs diet and usual diet instruction on Intestinal flora, intestinal short chain fatty acids and quality of life by two groups.The results will answer the effect and long-term safety of Low FODMAPs diet.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date March 2017
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Diagnostic criteria for Rome ?

- IBS patients with diarrhea type

- By endoscopy, X-ray, B ultrasound and laboratory examination to exclude organic disease

- Patients be able to communicate well with the researchers and be willing to participate in the study

Exclusion Criteria:

- Stomach, small intestine, colon surgery history

- irritable bowel disease (IBD) active period, celiac disease

- Alcoholics or drug abuse

- Pregnant or lactating women

- Recent drug users who use defecation

- Have a special diet

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Low FODMAPs Diet
Instruct to design and eat Low Fermentable,Oligo-,Di-,Mono-saccharides And Polyols(FODMAPs) Diet
Diet instruction
Answer the doubt and help the patient get the diet knowlege about the IBS.

Locations

Country Name City State
China YangzhouUniversity Yangzhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Jinsong Wang

Country where clinical trial is conducted

China, 

References & Publications (14)

Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Simrén M. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015 Nov;149(6):1399-1407.e — View Citation

Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013 May;108(5):634-41. doi: 10.1038/aj — View Citation

Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014 Nov;40(9):1023-34. doi: 10.1111/apt.12938. Epub 2014 Sep 9. Review. — View Citation

Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, McMeans AR, Luna RA, Versalovic J, Shulman RJ. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Al — View Citation

De Giorgio R, Volta U, Gibson PR. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut. 2016 Jan;65(1):169-78. doi: 10.1136/gutjnl-2015-309757. Epub 2015 Jun 15. Review. — View Citation

Eswaran S, Tack J, Chey WD. Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am. 2011 Mar;40(1):141-62. doi: 10.1016/j.gtc.2010.12.012. Review. — View Citation

Gibson PR, Varney J, Malakar S, Muir JG. Food components and irritable bowel syndrome. Gastroenterology. 2015 May;148(6):1158-74.e4. doi: 10.1053/j.gastro.2015.02.005. Epub 2015 Feb 11. Review. — View Citation

Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. — View Citation

Hyland NP, Quigley EM, Brint E. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. World J Gastroenterol. 2014 Jul 21;20(27):8859-66. doi: 10.3748/wjg.v20.i27.8859. Review. — View Citation

Iacovou M, Tan V, Muir JG, Gibson PR. The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil. 2015 Oct 1;21(4):459-70. doi: 10.5056/jnm15111. — View Citation

Jain I, Kumar V, Satyanarayana T. Xylooligosaccharides: an economical prebiotic from agroresidues and their health benefits. Indian J Exp Biol. 2015 Mar;53(3):131-42. Review. — View Citation

Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012 Jul;10(7):712-721.e4. doi: 10.1016/j.cgh.2012.02.029. Epub 2012 Mar 15. — View Citation

Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. 2016 Apr;55(3):897-906. doi: 10.1007/s00394-015-0922-1. Epub — View Citation

Whigham L, Joyce T, Harper G, Irving PM, Staudacher HM, Whelan K, Lomer MC. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritabl — View Citation

* Note: There are 14 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Microbiota / Short chain fatty acids The fecal samples of IBS patients were analyzed. Change from baseline Microbiota / Short chain fatty acids at 4 weeks No
Secondary Irritable bowel syndrome severity scoring system scale Irritable bowel syndrome severity scoring system scale is an integral system for monitoring the severity of IBS in patients with disease severity.The scale is mainly from the degree of abdominal pain, abdominal pain frequency, abdominal distension, defecation satisfaction and the impact of life, according to the 10cm visual scoring method Baseline,1,and 3 month post randomization No
Secondary The Short Form 36 (SF-36) scale SF-36 is a general scale, at present, the most commonly used evaluation of IBS. It includes 36 items, a total of 8 dimensions Baseline,1,and 3 month post randomization No
Secondary Irritable bowel syndrome quality of life (IBS-QOL) scale Irritable bowel syndrome quality of life (IBS-QOL) scale is a more extensive application of the specific scale of IBS. Baseline,1,and 3 month post randomization No
Secondary Satisfaction questionnaire To understand the patient's satisfaction with symptom control and diet guidance. The questionnaire included 3 items 1,and 3 month post randomization No
See also
  Status Clinical Trial Phase
Completed NCT03277040 - Diet, Eating, and Lifestyle Improvement for Valued Employees and Their Relatives N/A
Not yet recruiting NCT03266666 - Welcome to WellnessRX: Steps Toward a Healthier Life! N/A
Completed NCT03003923 - Promoting Vegetable Intake in Preschool Aged Children N/A
Completed NCT02309840 - The Modifying Eating and Lifestyles at School Study N/A
Completed NCT02729675 - Innovative Approaches to Increase F&V Intake Thru Worksites Phase 2
Completed NCT01156805 - Assessment of an School-based Intervention in Eating Habits and Physical Activity in Schoolchildren: the AVall Study N/A
Completed NCT00360919 - Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion Phase 0
Not yet recruiting NCT06258733 - Food Literacy Intervention - is a "Train the Trainer" Approach Feasible and Effective? N/A
Not yet recruiting NCT04493944 - Edible Seaweeds and Health: Quality Biomarkers to Support Consumer Acceptance N/A
Completed NCT04115852 - Interoceptive Nutritional Processing in Healthy Participants and Patients With Binge-Eating-Disorder
Completed NCT03340363 - "Make It Fresh, For Less" Supermarket Pilot Study N/A
Withdrawn NCT05073562 - Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia N/A
Completed NCT03941392 - Nutritional Study in Spanish Pediatric Population
Completed NCT03400566 - Effects of Experiential Learning on Vegetable Intake in Preschool Children N/A
Active, not recruiting NCT04262102 - The Dastatuz Project N/A
Recruiting NCT05773677 - Diet in Twin Pregnancy: the Wellness of Mother and Babies. N/A
Terminated NCT03283033 - School Lunch Salad Bars and Fruit and Vegetable Consumption N/A
Completed NCT03251664 - Food Groups Associated With Anaemia in Pregnant Women N/A
Completed NCT04586647 - Attitudes Toward Food During a Weight Loss Intervention N/A
Completed NCT03422939 - Dietary Guidelines, Portion Sizes, and Time Frame N/A